Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04752163
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2021-02-03
Brief Title:
DS-1594b With or Without Azacitidine Venetoclax or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-03
First Submit QC Date:
February 8 2021
Study First Post Date:
2021-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-14
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL